SEC 13F Intelligence

Argyle Capital Management, LLC / PFE

Argyle Capital Management, LLC’s Pfizer Inc Position

Does Argyle Capital Management, LLC own Pfizer Inc (PFE)? Yes — 151.9K shares worth $4M (+1.39% of its 13F portfolio) as of Q1 2026, up from 145.9K shares the prior filed quarter.

Position Value
$4M
Q1 2026
Shares
151.9K
% of Portfolio
+1.39%
Quarters Held
30
currently held

Position History PFE

Reported value by quarter
Q4 ’18: $7MQ4 ’18Q1 ’19: $6MQ2 ’19: $7MQ3 ’19: $6MQ4 ’19: $6MQ4 ’19Q1 ’20: $5MQ2 ’20: $5MQ3 ’20: $6MQ4 ’20: $6MQ4 ’20Q1 ’21: $6MQ2 ’21: $6MQ3 ’21: $7MQ4 ’21: $9MQ4 ’21Q1 ’22: $7MQ2 ’22: $7MQ3 ’22: $6MQ4 ’22: $7MQ4 ’22Q1 ’23: $6MQ2 ’23: $5MQ3 ’23: $5MQ4 ’23: $3MQ4 ’23Q1 ’24: $3MQ2 ’24: $4MQ3 ’24: $4MQ4 ’24: $4MQ4 ’24Q1 ’25: $4MQ2 ’25: $3MQ3 ’25: $4MQ4 ’25: $4MQ4 ’25Q1 ’26: $4Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026151.9K$4M+1.39%
Q4 2025145.9K$4M+1.21%
Q3 2025137.9K$4M+1.22%
Q2 2025138.2K$3M+1.21%
Q1 2025138.7K$4M+1.31%
Q4 2024134.8K$4M+1.41%
Q3 2024127.5K$4M+1.47%
Q2 2024132.6K$4M+1.53%
Q1 2024124.8K$3M+1.34%
Q4 2023117.3K$3M+1.40%
Q3 2023137.2K$5M+1.67%
Q2 2023137.2K$5M+1.81%
Q1 2023141.3K$6M+2.03%
Q4 2022141.3K$7M+2.49%
Q3 2022141.7K$6M+2.41%
Q2 2022141.5K$7M+2.66%
Q1 2022142.7K$7M+2.40%
Q4 2021149.2K$9M+2.75%
Q3 2021151.6K$7M+2.16%
Q2 2021151.9K$6M+1.92%
Q1 2021151.9K$6M+1.85%
Q4 2020151.9K$6M+2.08%
Q3 2020151.9K$6M+2.28%
Q2 2020153.5K$5M+2.11%
Q1 2020153.8K$5M+2.37%
Q4 2019153.5K$6M+2.14%
Q3 2019153.9K$6M+2.09%
Q2 2019153.2K$7M+2.52%
Q1 2019152.8K$6M+2.49%
Q4 2018152.8K$7M+2.82%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Argyle Capital Management, LLC’s full portfolio or all institutional holders of PFE.